EP2228064
Lyfjasamsetning sem inniheldur glýkópyrrólat og beta2 adrenviðtakaörva
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
17.5.2005EP published:
11.12.2019EP application number:
10164976.2
EP translation filed:
9.3.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
16.5.2025Expiry date:
16.5.2025
Title:
Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
Timeline
Today
17.5.2005EP application
11.12.2019EP Publication
9.3.2020Translation submitted
15.4.2020Registration published
16.5.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Collingwood, Stephen PaulAddress:
Horsham,, Sussex RH12 5AB, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0411056Date:
18.5.2004Country:
GB
Supplementary protection
SPC number:
SPC296
Classification
Categories:
A61K 31/402, A61K 31/4704, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 27.4.2020
Expires: 16.5.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 26.4.2021
Expires: 16.5.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 28.4.2022
Expires: 16.5.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 28.4.2023
Expires: 16.5.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 23.4.2024
Expires: 16.5.2025
Payer: Árnason Faktor ehf.